André Franken
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 22
- Breast Cancer Treatment Studies 6
- Cancer, Hypoxia, and Metabolism 1
- Oncology 8
- Cancer Cells and Metastasis 5
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Hans J. Neubauer (22 shared papers)Tanja Natascha Fehm (24 shared papers)Dieter Niederacher (19 shared papers)Johannes Fischer (4 shared papers)Nikolas Hendrik Stoecklein (4 shared papers)Christiane Driemel (4 shared papers)Franziska Meier-Stiegen (5 shared papers)Liwen Yang (8 shared papers)
In The Last Decade
André Franken
32 papers receiving 671 citations
Peers
Comparison fields: 5 of 49
- Cancer Research 357
- Oncology 183
- Biochemistry 23
- Biomedical Engineering 108
- Pulmonary and Respiratory Medicine 77
Countries citing papers authored by André Franken
This map shows the geographic impact of André Franken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Franken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Franken more than expected).
Fields of papers citing papers by André Franken
This network shows the impact of papers produced by André Franken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Franken. The network helps show where André Franken may publish in the future.
Co-authors
The 25 scholars most cited alongside André Franken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2018 | 65 | |
| 3 | 2023 | 58 | |
| 4 | 2016 | 48 | |
| 5 | 2017 | 41 | |
| 6 | 2019 | 36 | |
| 7 | 2023 | 35 | |
| 8 | 2020 | 32 | |
| 9 | 2023 | 31 | |
| 10 | 2019 | 28 | |
| 11 | 2019 | 27 | |
| 12 | 2019 | 23 | |
| 13 | 2021 | 22 | |
| 14 | 2023 | 18 | |
| 15 | 2017 | 16 | |
| 16 | 2021 | 13 | |
| 17 | 2021 | 10 | |
| 18 | 2024 | 7 | |
| 19 | 2020 | 4 | |
| 20 | 2022 | 4 |
About André Franken
André Franken is a scholar working on Cancer Research, Oncology, Genetics, Molecular Medicine and Immunology, having authored 35 papers that have together received 683 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (22 papers), Breast Cancer Treatment Studies (6 papers), Cancer Cells and Metastasis (5 papers), Estrogen and related hormone effects (5 papers), Pancreatic and Hepatic Oncology Research (2 papers), Hydrogels: synthesis, properties, applications (2 papers), Microfluidic and Bio-sensing Technologies (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (357 citations), Oncology (183 citations), Biochemistry (23 citations), Biomedical Engineering (108 citations) and Pulmonary and Respiratory Medicine (77 citations). André Franken has collaborated with scholars based in Germany, China and Australia. Frequent co-authors include Hans J. Neubauer, Tanja Natascha Fehm, Dieter Niederacher, Johannes Fischer, Nikolas Hendrik Stoecklein, Christiane Driemel, Franziska Meier-Stiegen, Liwen Yang, Volker Endris and Rita Lampignano. Their work appears in journals such as Cancers, Cytometry Part A, Clinical Chemistry, Applied Sciences and Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.